IHH Healthcare Looks Attractive on Recent Share Price Weakness

Dow Jones

1 hour ago

0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2673049067"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2673049067\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2673049067?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-08 09:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2673049067","market":"nz","top_or_hot":-1,"title":"IHH Healthcare Looks Attractive on Recent Share Price Weakness","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Looks Attractive on Recent Share Price Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Looks Attractive on Recent Share Price Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-10-08 09:08</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0029874061.USD","symbol_name":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2673049067","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2673049067","pubTimestamp":1791421680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4581":"高盛持仓","LABU":"三倍做多标普生物-Direxion","HCSG":"Healthcare Svcs Group Inc","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK4137":"综合支持服务","XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","BK4585":"ETF&股票定投概念","XLV":"健康照护类股ETF-SPDR"},"translate_title":"由于近期股价疲软，IHH Healthcare 看起来很有吸引力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"LABU":0.6,"HCSG":1.5,"XBI":0.6},"content_text":"0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}